Tara Marie Watson

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 170 citations · Full text

Losing the uphill battle? Emergent harm reduction interventions and barriers during the opioid overdose crisis in Canada

Carol Strıke, Tara Marie Watson · International Journal of Drug Policy · 2019 · 112 citations

Opioid Epidemic, Substance Abuse, Substance Use +13

Risk creating and risk reducing: Community perceptions of supervised consumption facilities for illicit drug use

Gillian Kolla, Carol Strıke, Tara Marie Watson et al. · Health Risk & Society · 2017 · 80 citations

Critical studies of harm reduction: Overdose response in uncertain political times

Tara Marie Watson, Gillian Kolla, Emily van der Meulen et al. · International Journal of Drug Policy · 2019 · 56 citations

Substance Abuse, Public Policy, Overdose Response +12

Increasing public support for supervised injection facilities in Ontario, Canada

Carol Strıke, Jennifer A. Jairam, Gillian Kolla et al. · Addiction · 2014 · 49 citations